A FAB mapping study of glucagon is described. The absence of important structural information led to a further investigation of the phenomenon. It is suggested that the presence of surface active components in mixtures of peptides can seriously affect the results. It may, in the case of unknown structures, lead to incorrect assignments.
No takes yet. Share an insight, caveat, or question.
Clench et al. (1985) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: